EVI Industries, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by EVI Industries, Inc. on December 12, 2024, regarding events occurring at the Company's Annual Meeting of Stockholders held on the same date. The Company is incorporated in Delaware and trades on the NYSE American under the symbol EVI.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance and equity plan amendments.
Material Changes and Voting Results
Stockholders approved two key proposals at the Annual Meeting:
- Election of Directors: All six nominees were elected for terms expiring at the 2025 Annual Meeting. Voting results were as follows:
- Henry M. Nahmad: 11,150,874 For; 1,218,633 Withheld
- Dennis Mack: 11,482,372 For; 887,135 Withheld
- David Blyer: 10,064,077 For; 2,305,430 Withheld
- Glen Kruger: 12,295,158 For; 74,349 Withheld
- Timothy P. LaMacchia: 11,533,014 For; 836,493 Withheld
- Hal M. Lucas: 10,818,911 For; 1,550,596 Withheld
- Amendment of 2015 Equity Incentive Plan: Stockholders approved an amendment to increase the authorized share pool from 3,000,000 to 3,500,000 shares. The amendment also provides for the automatic acceleration of vesting or exercisability of outstanding awards upon a Change in Control, with specific exceptions for the controlling stockholder.
- Votes For: 8,865,180
- Votes Against: 2,837,621
- Abstentions: 666,706
Guidance, Outlook, and Risks
The filing does not provide management guidance, financial outlook, or discuss specific operational risks. The primary corporate action involves the modification of the equity incentive structure to align with potential change-in-control scenarios.
Investor Verification Checklist
- Verify the full text of the amended 2015 Equity Incentive Plan (Exhibit 10.1) to understand the specific terms of the Change in Control acceleration and controlling stockholder exceptions.
- Review the Definitive Proxy Statement (Schedule 14A) filed on November 20, 2024, for detailed descriptions of the director nominees and the rationale for the equity plan amendment.
- Confirm the impact of the increased share authorization (500,000 additional shares) on potential future dilution.